Activation of 5-HT2A receptors potentiates pain produced by inflammatory mediators

Neuropharmacology

Volumn 35, Issue 1, 1996, Pages 99-110

  Abbott, F V ^a   Hong, Y ^a   Blier, P ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

5 HT2A receptor; 5 hydroxytryptamine; Analgesia; Formalin test; Inflammation; Pain; Serotonin receptor subtypes

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; PROSTAGLANDIN E2; SEROTONIN; SEROTONIN RECEPTOR; 2 METHYLSEROTONIN; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; FORMALDEHYDE; KETANSERIN; NORADRENALIN; RECEPTOR SUBTYPE; RITANSERIN; SEROTONIN 2A RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SPIPERONE;

ANIMAL; ANIMAL BEHAVIOR; ARTICLE; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG EFFECT; INFLAMMATION; MALE; PAIN; RAT; ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; BEHAVIOR; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; BEHAVIOR, ANIMAL; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; INFLAMMATION; MALE; PAIN; RATS; RECEPTORS, SEROTONIN; SEROTONIN;

EID: 0029670750     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/0028-3908(95)00136-0     Document Type: Article

References (44)

1. Abbott F. V., Franklin K. B. J. and Westbrook R. F. (1995) The formalin test: scoring properties of first and second phases of the pain response in rats. Pain 60: 91-102.
2. 7) positively linked to adenylate cyclase. J. Biol. Chem. 268: 23422-23426.
3. Berenbaum M. C. (1989) What is synergy? Pharmac. Rev. 41: 93-141.
4. Bleehen T. and Keele C. A. (1977) Observations on the algogenic actions of adenosine compounds on the human blister base preparation. Pain 3: 367-377.
5. Boess F. G. and Martin I. L. (1994) Molecular biology of 5-HT receptors. Neuropharmacology 33: 275-317.
6. Coderre T. J., Fundytus M. E., McKenna J. E., Dalal S. and Melzack R. (1993) The formalin test: a validation of the weighted-scores method of behavioural pain rating. Pain 54: 43-50.
7. 3 antagonist on carrageenan-induced hyperalgesia in rats. Pain 36: 249-255.
8. Franklin K. B. J. and Abbott F. V. (1989) Techniques for assessing the effects of drugs on nociceptive responses. In: Neuromethods: Vol. 13, Psychopharmacology I (Boulton A. A., Baker C. B. and Greenshaw A. J., Eds), pp. 145-216. Humana Press, Clifton, N. J.
9. Giordano J. and Dyche J. (1989) Differential analgesic actions of serotonin 5-HT3 receptor antagonists in the mouse. Neuropharmacology 28: 423-427.
10. Giordano J. and Rogers L. V. (1989) Peripherally administered serotonin 5-HT3 receptor antagonists reduce inflammatory pain in rats. Eur. J. Pharmac. 170: 83-86.
11. Greaves M. and Shuster S. (1967) Responses of skin blood vessels to bradykinin, histamine and 5-hydroxytryptamine. J. Physiol., Lond. 193: 255-267.
12. Green A. F., Garland L. G. and Hodson H. F. (1979) Antagonists of histamine, 5-hydroxytryptamine and SRS-A. In: Handbook of Experimental Pharmacology, Vol. 50/II, Anti-inflammatory Drugs (Vane J.R. and Ferreira S.H., Eds), pp. 414-466. Springer-Verlag, Berlin.
13. Holmsen H. and Weiss H. J. (1979) Secretable stroage pools in platelets. A. Rev. Med. 30: 119-134.
14. Hong Y. and Abbott F. V. (1994) Behavioural effects of intraplantar injection of inflammatory mediators in the rat. Neuroscience 63: 827-836.
15. Hong Y. and Abbott F. V. (1995) Peripheral opioid modulation of pain and inflammation in the formalin test. Eur. J. Pharmac. 277: 21-28.
16. 3 Antagonists and Benzodiazepines: Their Comparitive Behavioural Pharmacology (Rodgers R.J. and Cooper S.J., Eds), pp. 31-57. John Wiley and Sons Ltd, London
17. Hoyer D., Clarke D. E., Fozard J. R., Hartig P. R., Martin G. R., Mylecharane E. J., Saxena P. R. and Humphrey P. P. A. (1994) International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmac. Rev. 46: 157-203.
18. Jensen K., Tuxen C., Pedersen-Bjergaard U., Jansen I., Edvinsson L. and Olesen J. (1990) Pain and tenderness in human temporal muscle induced by bradykinin and 5-hydroxytryptamine. Peptides 11: 1127-1132.
19. Jensen K., Tuxen C., Pedersen-Bjergaard U. and Jansen I. (1991) Pain, tenderness, wheal and flare induced by substance-P, bradykinin and 5-hydroxytryptamine in humans. Cephalagia 11: 175-182.
20. Keele C. A. and Armstrong D. (1964) Substances Producing Pain and Itch. Edward Arnold Ltd, London,
21. Kelly S. J. and Franklin K. B. J. (1985) An increase in tryptophan may be a general mechanism for the effect of stress on sensitivity to pain. Neuropharmacology 24: 1019-1025.
22. Levine J. D., Taiwo Y. O., Collins S. D. and Tam J. K. (1986) Noradrenaline hyperalgesia is mediated through interaction with sympathetic postganglionic neurone terminals rather than activation of primary afferent nociceptors. Nature 323: 158-160.
23. 2-receptors: location, pharmacological, pathological and physiological role. In: Serotonin Receptor Subtypes: Pharmacological Significance (Langer S.Z., Brunello N., Racagni G. and Mendlewicz J., Eds), pp. 31-43. Karger, Basel.
24. Lindahl O. (1961) Experimental skin pain induced by injection of water-soluble substances in humans. Acta Physiol. Scand. 51 (suppl.179): 1-90.
25. Lynn B. (1977) Cutaneous hyperalgesia. Br. Med. Bull. 33: 103-108.
26. 2 receptor antagonism. Clin. Exp. Physiol. Pharmac. 21: 955-961.
27. Mosteller F. and Tukey J. W. (1968) Data analysis, including statistics. In: Handbook of Social Psychology (Lindsey G. and Aronson E., Eds), pp. 80-203. Addison-Wesley, Reading, MA.
28. Porters J., Roekaerts F. and Reyntjens A. (1981) Effects of ketanserin in superficial venous thromosis. Curr. Ther. Res. 30: 499-506.
29. Quenouille M. (1956) Notes on bias in estimation. Biometrika 43: 353-360.
30. Rang H. P., Bevan S. and Dray A. (1991) Chemical activation of nociceptive peripheral neurones. Br. Med. Bull. 47: 534-548.
31. Richardson B. P., Engel G., Donatsch P. and Stadler P. A. (1985) Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature 316: 126-131.
32. Ringkamp M., Schmelz M., Allwang M., Ogilvie A. and Reeh P. W. (1994) Nociceptor excitation by platelets is not due to 5-HT or prostanoids released. Soc. Neurosci. Abs. 20: 643.6(Abstract)
33. Rueff A. and Dray A. (1992) 5-hydroxytryptamine-induced sensitization and activation of peripheral fibres in the neonatal rat are mediated via different 5-hydroxytryptamine-receptors. Neuroscience 50: 899-905.
34. Sicuteri F., Fanciullacci M., Franchi G. and Del Bianco P. L. (1965) Serotonin - Bradykinin potentiation on the pain receptors in man. Life Sci. 4: 309-316.
35. 1B-adrenoceptors. Eur. J. Pharmac. 238: 407-410.
36. Sufka K. J., Schomberg F. M. and Giordano J. (1992) Receptor mediation of 5-HT-induced inflammation and nociception in rats. Pharmac. Biochem. Behav. 41: 53-56.
37. Taiwo Y. O., Goetzl E. J. and Levine J. D. (1987) Hyperalgesia onset latency suggests a hierarchy of action. Brain Res. 423: 333-337.
38. Taiwo Y. O., Heller P. H. and Levine J. D. (1992) Mediation of serotonin hyperalgesia by the cAMP second messenger system. Neuroscience 48: 479-483.
39. Taiwo Y. O. and Levine J. D. (1992) Serotonin is a directly-acting hyperalgesic agent. Neuroscience 48: 485-490.
40. Terman G. W., Shavit Y., Lewis J. W., Cannon T.J. and Liebeskind J.C. (1984) Intrinsic mechanisms of pain inhibition: activation by stress. Science 226: 1270-1277.
41. Thomas L. (1971) Adaptive aspects of inflammation. In: Immunopathology of Inflammation (Forscher B. K. and Houck J. C., Eds) Exerpta Medica, Amsterdam, pp. 1-10.
42. Tjølsen A., Berge O.-G., Hunskaar S., Rosland J. H. and Hole K. (1992) The formalin test: an evaluation of the method. Pain 51: 5-17.
43. 2B receptors. IUPHAR Satelite Meeting on Serotonin 3: 76.
44. White D. M., Taiwo Y. O., Coderre T. J. and Levine J. D. (1991) Delayed activation of nociceptors: correlation with delayed pain sensations induced by sustained stimuli. J. Neurophysiol. 66: 729-734.